Ensayos clínicos

8.676 ensayos encontrados

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3b, Multi-center, Randomized, Parallel-group, Open-label, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Oral Dolutegravir/Lamivudine Once-daily as a First-line Regimen Compared to Oral Bictegravir/Emtricitabine/Tenofovir Alafenamide Once Daily for Virologic Suppression and Maintenance in Antiretroviral Therapy Naive Adults Living With HIV

INTERVENTIONALInicio: 9 de feb de 2024ID: NCT05979311

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

INTERVENTIONALInicio: 6 de may de 2025ID: NCT06747351

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study of Adjuvant MK-7684A (Vibostolimab With Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants With High-risk Stage II-IV Melanoma (KEYVIBE-010)

INTERVENTIONALInicio: 19 de ene de 2023ID: NCT05665595

CompletadoClinicalTrials.gov

Retrospective Cohort Study of Rebif® Use in Pediatric MS Patients

OBSERVATIONALInicio: 1 de jul de 2010ID: NCT01207648

DesconocidoFase 2ClinicalTrials.gov

Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina

INTERVENTIONALInicio: 3 de ago de 2021ID: NCT04988048

CompletadoFase 3ClinicalTrials.gov

A Randomized, Open-label Trial to Compare the Efficacy, Safety and Tolerability of DRV/Rtv (800mg/100mg) q.d Versus DRV/Rtv (600mg/100mg) b.i.d in Early Treatment-experienced HIV-1 Infected Subjects

INTERVENTIONALInicio: 1 de oct de 2007ID: NCT00524368

CompletadoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFa Monoclonal Antibody, Administered Intravenously, in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

INTERVENTIONALInicio: 1 de sept de 2006ID: NCT00361335

ReclutandoFase 3ClinicalTrials.gov

A Phase IIIB, Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition

INTERVENTIONALInicio: 14 de may de 2024ID: NCT06134362

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Immunoglobulin A Nephropathy (IgAN)

INTERVENTIONALInicio: 29 de mar de 2024ID: NCT06291376

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function

INTERVENTIONALInicio: 11 de dic de 2020ID: NCT04573478

CompletadoFase 2ClinicalTrials.gov

A Proof of Concept Study for GSK2248761 (An Extension of NV-05A-002: A Phase I/IIa Double-Blind Study to Evaluate the Safety and Tolerability, Antiretroviral Activity, Pharmacokinetics and Pharmacodynamics of IDX12899 in Antiretroviral Treatment-Naive HIV-1 Infected Subjects, Completed by Idenix)

INTERVENTIONALInicio: 20 de oct de 2009ID: NCT00945282

CompletadoFase 4ClinicalTrials.gov

PHASE IV, MULTICENTRIC, DOUBLE-BLIND, RANDOMIZED, CONTROLLED,60 DAYS, PARALLEL GROUPS, SUPERIORITY STUDY, TO COMPARE THE EFFECTIVENESS AND TOXICITY OF BEPOTASTINE 1.5% PF vs. OLOPATADINE 0.2% WITH BAK IN TREATMENT OF ALLERGIC CONJUNCTIVITIS

INTERVENTIONALInicio: 10 de mar de 2021ID: NCT04776096

CompletadoFase 2ClinicalTrials.gov

A Phase II, Randomised, Double-blind, Dose-ranging Study of AVX754 Versus Lamivudine in Treatment-experienced HIV-1 Infected Patients With the M184V Mutation in Reverse Transcriptase

INTERVENTIONALInicio: 1 de jul de 2005ID: NCT00126880

TerminadoFase 3ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy (ARTEMIS - IGAN)

INTERVENTIONALInicio: 5 de abr de 2018ID: NCT03608033

CompletadoFase 4ClinicalTrials.gov

Phase IV Open Label Uncontrolled Trial of the Dual Blockade of the Renin Angiotensin System With Enalapril Plus Valsartan Combined With Oral Methylprednisolone for the Treatment of Proteinuria in IGA Nephropathy

INTERVENTIONALInicio: 1 de ene de 1996ID: NCT00367562

ReclutandoClinicalTrials.gov

SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)

OBSERVATIONALInicio: 7 de feb de 2025ID: NCT07342621

CompletadoClinicalTrials.gov

Clinical and Immunologic Impact of SARS-CoV-2 in Hospitalized Pregnant Women and Neonates in Argentina

OBSERVATIONALInicio: 10 de jul de 2020ID: NCT04362956

DesconocidoFase 3ClinicalTrials.gov

MULTICENTER, RANDOMIZED, DOUBLE BLIND, CONTROLLED, CLINICAL STUDY TO DEMONSTRATE THE THERAPEUTIC CLINICAL EQUIVALENCE OF TWO MOMETASONE NASAL SPRAYS IN THE RELIEF OF THE SIGNS AND SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS.

INTERVENTIONALInicio: 1 de oct de 2012ID: NCT01702103

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult Participants With Active IgG4-related Disease

INTERVENTIONALInicio: 26 de sept de 2025ID: NCT07190196

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Multinational, Open-Label Extension Study to Evaluate the Long-Term Safety of CC-93538 in Adult and Adolescent Subjects With Eosinophilic Esophagitis

INTERVENTIONALInicio: 14 de sept de 2021ID: NCT04991935